Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Nasopharyngeal Cancinoma (NPC) × Immune Checkpoint Inhibitors × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Nasopharyngeal Carcinoma 2 Esophageal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Nasopharyngeal Cancinoma (NPC) 1 Melanoma 1 Carcinoma, Hepatocellular 1 Anus Neoplasms 1 Anal Canal Carcinoma 1

Interventions

Radiotherapy, Intensity-Modulated 1 Immune Checkpoint Inhibitors 1 Cisplatin 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07238569 2025-11-20

Phase III Trial of EBV-DNA-Guided Adaptive Immunotherapy for Advanced Nasopharyngeal Carcinoma

Sun Yat-sen University

Phase 3 Not yet recruiting

Nasopharyngeal Cancinoma (NPC)

Data powered by HemOnc (CC BY 4.0) Colophon ⚡